(Q28195719)

Europe PubMed Central

PubMed publication ID

12706634

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706634

full work available at URL

26 December 2023

language of work or name

English

0 references

publication date

25 January 2003

0 references

https://api.elsevier.com/content/article/PII:S0049384803000951?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(03)00095-1

https://api.elsevier.com/content/article/PII:S0049384803000951?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(03)00095-1

26 December 2023

0 references

109

0 references

issue

2-3

0 references

page(s)

73-81

0 references

cites work

Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Coagulation and fibrinolytic mechanisms during and after normal childbirth

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Fibrinolytic enzyme system and pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

TAFI antigen and D-dimer levels during normal pregnancy and at delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Thrombosis in pregnancy: maternal and fetal issues

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Antiphospholipid antibodies and reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Increased thrombin generation in women with recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

The Nature and Significance of Platelet Products in Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Increased fetal loss in women with heritable thrombophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Activated protein C resistance can be associated with recurrent fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Inherited thrombophilia and fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Increased risk for fetal loss in carriers of the factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Mutations in coagulation factors in women with unexplained late fetal loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

First-trimester repeated abortion is not associated with activated protein C resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Absence of association of thrombophilia polymorphisms with intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Use of antithrombotic agents during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900095-1

7 January 2021

Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation

4

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(03)00095-1

Increased intravascular coagulation associated with pregnancy

26 December 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(03)00095-1

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience

26 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(03)00095-1

Blood-borne tissue factor: another view of thrombosis

26 December 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(03)00095-1

Genetic hypofibrinolysis in complicated pregnancies

26 December 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0049-3848(03)00095-1

26 December 2023

Identifiers

release_kld5ogrvbzcunjn2dltsxi77qe

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kld5ogrvbzcunjn2dltsxi77qe

24 November 2022